CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

<p>Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis.</p> <p>Show references<a class="waffle-rich-text-link" href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2107454">:</a> <a class="waffle-rich-text-link" href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2107454">https://www.nejm.org/doi/full/10.1056/NEJMoa21074</a>54</p> <p> </p>